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Non-pharmacological rhythm control of atrial ﬁbrillation (AF) is becoming increasingly important in
our aging society. Advancement of catheter ablation techniques in the last decade has provided a
cure for AF patients, with a nearly established efﬁciency for paroxysmal cases. However, since ablation
of persistent/chronic AF cases is still challenging, early treatment of paroxysmal AF before transforma-
tion to the persistent/chronic form is mandatory. Although there is a consensus that pulmonary
vein isolation is the ﬁrst-line approach for ablation of long-standing persistent AF, similar to that
for paroxysmal AF, there are still wide variations in the adjunctive approach to modify the atrial
substrate of persistent AF (anatomical linear ablation, electrogram-based complex fractionated atrial
electrogram ablation, ganglionated plexus ablation, etc.). Since data comparing the effectiveness of
these adjunctive approaches are still lacking, large-scale controlled trials evaluating the effect of
catheter ablation in diverse patient populations on a long-term basis are needed to establish the
appropriate approach for long-standing persistent AF. Furthermore, the development of de novo
ablation methods (new energies, new targets, etc.) is expected to improve ablation outcome in patients
with long-standing persistent AF.
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Since the landmark paper published by Haissaguerre et al.
demonstrating the pulmonary veins (PVs) as the dominant
triggers of paroxysmal atrial ﬁbrillation (AF), the efﬁcacy of
radiofrequency catheter ablation for atrial ﬁbrillation has been
established. After the initial attempt to ablate the ﬁring foci of the
PVs, PV isolation (PVI) has become the main target in cases of
paroxysmal AF. In contrast, the role of the atrial substrates thatrt Rhythm Society. Published by Emaintain atrial ﬁbrillation increases during AF progression from
paroxysmal to the long-persistent form, which requires adjunc-
tive treatment in addition to PVI. Years have passed since the
numerous novel catheter-based approaches for long-persistent AF
have been addressed; therefore, the debate still remains concern-
ing the indications for catheter ablation, the approaches appro-
priate in each case, and the endpoints of ablative therapy. In this
review, we focus on the current approaches for catheter ablation
of long-lasting persistent AF cases.
This review summarizes the current ablative techniques and
emphasizes the appropriate applications and limitations of cathe-
ter ablation for long-lasting persistent AF.lsevier B.V. All rights reserved.
Fig. 2. Clinical success of various ablation techniques for persistent/long-standing
persistent AF. The rates shown are for single-procedure, drug-free success (white),
multiple-procedure success (diagonal crosshatch), and antiarrhythmic drug
(AAD)-assisted success (dark double hatch). LIN¼conventional linear ablation;
PVA¼pulmonary vein antrum ablation; PVAI¼PV antrum isolation. Reproduced
from Ref. [8].
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It is well known that PVI was ﬁrst developed to eliminate the
triggers that initiate attacks of paroxysmal atrial ﬁbrillation [1].
Subsequently, the additional function of the PV myocardium
to perpetuate atrial ﬁbrillation has been a focus [2]. Now, most
approaches for eliminating long-persistent atrial ﬁbrillation
include PVI as the baseline procedure to reduce both the trigger
and the maintaining factor of persistent AF. Although variations
still exist in the procedures that target the PVs, including
circumferential PV ablation (CPVA), [3] extensive encircling PV
isolation (EEPVI), [4] PV antrum isolation (PVAI), [5] and BOX
isolation [6] (Fig. 1), there is a common consensus among them
[7]. To reduce the risk of PV stenosis and eliminate the ﬁring foci
around the PV ostium, ablations should be performed in the atrial
tissue located in the antrum rather than the PV ostium. If the PVs
are targeted, complete electrical isolation should be the goal.
Radiofrequency (RF) energy can be applied either segmentally,
guided by a circular mapping catheter, or by a continuous
circumferential ablation lesion created to surround the ipsilateral
right or left PVs.
Analysis of 4 major articles in which antral encirclement of PVs
in cases with long-standing persistent AF underwent a single-
procedure, showed a drug-free success rate ranging from 37%
to 56% at approximately 1 year (Fig. 2) [8]. Integration of repeat
procedures (mean, 1.3 per patient) increased the drug-free success
rate to 59%. The combination of drugs and multiple procedures
yielded a success rate of approximately 77%.Fig. 1. Variations in the pulmonary vein isolation methods. (A) CPVA/CPVI (Circumfere
(PV antrum isolation), and (D) BOX isolation.3. Adjunctive ablation strategies (electrogram-guided
ablation and linear ablation)
Although ablation strategies targeting the PVs are the corner-
stone of AF ablation procedures for both paroxysmal and persistent
AF, continued efforts are underway to establish additive strategies
to improve ablation outcome. Currently, one of the most popular
methods for AF-substrate modiﬁcation in the atrium is to apply
RF energy and create lesions targeting the areas with complexntial PV ablation/isolation), (B) EEPVI (Extensive encircling PV isolation), (C) PVAI
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by Nademanee et al. (Fig. 3) [9]. CFAEs are believed to represent
slow conduction or pivot points where wavelets turn around at
the end of arcs of functional blocks, and are deﬁned as atrial
electrograms with fractionations, continuous activity, or rapid
ﬁrings with very short cycle lengths of r120 ms averaged over
a 10-s recording period. The primary endpoint of ablation in
their original work was either complete elimination of the area
with CFAEs or conversion of AF to sinus rhythm. CFAE ablation
terminated AF in 49 of 57 patients with paroxysmal AF (86%)
and 40 of 64 patients with chronic AF (63%) without the use of
antiarrhythmic drugs. The AF-free rate at 1-year follow-up was
91% in 110 patients, including those who underwent repeat
procedures (16%).Fig. 3. Electrogram-guided complex fractionated atrial electrogram (CFAE) ablation: C
Fig. 4. Meta-analysis demonstrated that adjunctive CFAE ablation only provided a ben
atrial tachyarrhythmias for paroxysmal AF. (B) Freedom from atrial tachyarrhythmiasAlthough this method is well accepted, its role in ablation has not
yet been fully established. CFAE ablation only targets the substrate
that perpetuates AF, in fact only a modest effect on chronic AF has
been reported thus far [10]. More recently, a general consensus has
been established that CFAE ablation is regarded as a combination
strategy for modifying the AF substrate as discussed below.
A recent meta-analysis of randomized controlled trials on the
effectiveness of additional CFAE ablation on PVI [11–13] showed no
beneﬁt for CFAE ablation as a single approach. However, a signiﬁcant
beneﬁt was shown for adjunctive CFAE ablation in addition to PVI in
persistent AF cases, but not in paroxysmal AF cases (Fig. 4).
Based on advancements in 3D mapping systems, CFAEs
can be targeted either in a subjective (physician interpretation)
or objective (online CFAE detection algorithms) manner. One ofFAEs are targeted with the help of the CARTO system (reproduced from Ref. [9]).
eﬁt in non-paroxysmal AF cases, but not in paroxysmal cases. (A) Freedom from
for nonparoxysmal AF.
Linear Ablation LA-Roof Line
Hocini M.
Circulation.2005;112:3688
Jais P,
Circulation. 2004;110:2996
Mitral Isthmus Line
Fig. 5. Left atrial linear ablation targeting the roof and the left isthmus between the mitral valve and the left inferior PV. Reproduced from Refs. [15,16].
Fig. 6. Sigmoidal relationship between the progression of stepwise ablations and
the AF termination rate. Reproduced from Ref. [20].
T. Yamane / Journal of Arrhythmia 28 (2012) 155–161158the ﬁrst attempts to objectively quantify (CARTO, Biosense
Webster, Diamond Bar, CA, USA) and target CFAE in addition
to conventional ablation was reported by Hayward et al. [13].
The algorithms yielded primary CFAE sites in the atrium in an
average of 24% of the cases, which were accordingly ablated. PVAI
and other line ablations (roof and mitral isthmus) were also
performed. During the follow-up period (41 year), they reported
a 68% clinical (drug-free) success rate after a single procedure in
long-standing persistent AF patients [14].
The efﬁciency of 2 additional strategies for eliminating the
substrate for AF maintenance in addition to PVI has been described.
Linear lesions are commonly made at the roof between the
contralateral superior PVs (roof line), and at the isthmus between
the mitral valve and the left inferior PV (mitral isthmus line) (Fig. 5).
This concept was based on previous reports by Hocini et al. [15] and
Jaı¨s et al. [16], in which the combination of both the roof line and the
mitral isthmus line improved the AF-free ratio in paroxysmal AF
cases from 69% to 87%; however, epicardial RF applications were
required in 60% of the cases to achieve the mitral isthmus block.
Meta-analysis showed that although the addition of linear lesions
did not confer a signiﬁcant beneﬁt in freedom from AF over PVI
alone, a signiﬁcant beneﬁt was observed for the addition of linear
lesions to PVI in persistent AF cases (RR, 0.53) [11].
Adding ganglionated plexus (GP) ablation as an adjunctive
approach to other targets may improve ablation success. The
4 major left atrial (LA) GPs (superior left, inferior left, anterior
right, and inferior right GP) are located in epicardial fat pads at
the border of the PV antrum and can be localized at the time of
ablation using high frequency endocardial stimulation [17]. RF
current can be applied endocardially at each site with a positive
vagal response to high frequency stimulation until the vagal
response to high frequency stimulation is eliminated. Although
ablation of the left atrial GP has been shown to produce promising
results in terms of eliminating the paroxysmal form of AF, its role
in ablation of persistent AF remains unclear. Pokushalov et al. [18]
demonstrated that GP ablation alone showed only limited effec-
tiveness (38.2%) for long-term maintenance of sinus rhythm inlong-standing persistent AF, while the addition of antral PVI
resulted in a better success rate (59.6%) over a follow-up period
of approximately 1.5 years.4. Sequential multifaceted ablation strategy for chronic AF
Multiple strategies consisting of various procedures, including
PVI, anatomy- or electrogram-guided left atrial ablation, linear
ablation, and thoracic vein isolation, have been developed as
discussed above. Each strategy alone has been shown to yield
similar success rates (50–70%), suggesting various coexisting
targets and factors as modiﬁers of AF substrates. The stepwise
ablation approach is an integration of most of the aforementioned
techniques in a bid to additively improve the success of long-
standing persistent AF ablation [19]. Each region is targeted in
sequence, with the effect of ablation assessed by measuring AF
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to sinus rhythm. According to the progression of the stepwise
procedure, the AF-termination rate increased in a sigmoidal
fashion (Fig. 6) [20]. Thus far, 5 studies have reported the clinical
success associated with the stepwise ablation approach for
persistent/long standing persistent AF [19–24]. In an original
article by Haissaguerre et al. [19] the single-procedure, drug-free
success rate was 62% in 1176 months, which increased to 88%
when repeat procedures were performed in almost 50% of
patients. Subsequent articles have demonstrated substantially
lower outcomes with success rates of 23–55% when using a single
procedure [21–24]. Integration of repeat procedures, mostly for
focal atrial tachycardia and ﬂutter, increased the drug-free clinical
success rate to 70–88%, and the allowance of previously ineffec-
tive antiarrhythmic drug treatment further improved clinical
success to 84–90% (Fig. 2) [8].Fig. 7. A representative case demonstrating a signiﬁcant reduction of continuous f
and linear ablation in the left atrium. (A) The regions presenting CFAEs were demonstra
PV isolation, the regions demonstrating CFAEs were decreased. (C) The linear abla
Ref. [25].5. A comparison of and the relationship between
2 approaches for long-standing persistent AF: CFAE ablation
and linear ablation
As mentioned above, both electrogram-based ablation targeting
the CFAEs and linear ablation in the left atrium, including rooﬂine
ablation and mitral isthmus ablation, have been performed in
combination with PVI to eliminate long-persistent atrial ﬁbrilla-
tion. Although all these strategies have been shown to be effective,
there have been only a few reports demonstrating the relationship
between these approaches. PVI has been shown to signiﬁcantly
reduce CFAE regions, and additional ablation targeting the residual
CFAE can terminate and eliminate AF during subsequent observa-
tion. Matsuo et al. [25] recently demonstrated that both PVI and LA
linear ablation resulted in a signiﬁcant reduction of CFAE areas, not
only in the areas where RF was applied, but also in remote regionsractionated atrial electrograms (CFAEs) through pulmonary vein (PV) isolation
ted by high-density mapping prior to radiofrequency application. (B) Following the
tions resulted in a signiﬁcant reduction of the CFAE areas. Reproduced from
T. Yamane / Journal of Arrhythmia 28 (2012) 155–161160without RF energy application (Fig. 7). Therefore, reducing the
CFAE areas through LA linear ablation could be useful for decreas-
ing the RF energy required for CFAE ablation.
Data comparing the effectiveness of CFAE ablation and LA
linear ablation for eliminating long-standing persistent AF is
lacking. However, Estner et al. recently showed that CFAE ablation
plus PVI in patients with persistent AF ablation approached the
same effectiveness as circumferential PVI plus line within the ﬁrst
year after a single ablation procedure [26]. Prospective, rando-
mized studies comparing the effectiveness of CFAE and line
ablation with the baseline PVI protocol are needed to determine
the actual effectiveness of each adjunctive ablation method.6. Endpoint of catheter ablation for long-standing persistent AF
There remains a debate on the endpoint of ablation for long-
standing persistent AF cases. O’Neill et al. reported that proce-
dural AF termination during stepwise ablation, involving PVI,
CFAE-ablation, and linear atrial ablation, had a better subsequent
clinical outcome than cases without procedural AF termination,
and suggested AF termination as the desirable endpoint of the
procedure [22]. However, this result has not been reproducible in
other studies. Recently published data by Lo et al. [27] and Elayi
et al. [28] showed similar results; cases both with and without
procedural AF termination had similar subsequent clinical out-
comes and AF termination is a phenomenon that is likely to be
achieved only in less advanced cases. When we look back at the
paper by O’Neill et al. [20], we observed a signiﬁcant difference in
the baseline characteristics of patients with and without proce-
dural AF termination, which suggests that AF termination itself
may only be a surrogate for less advanced atrial disease. It is still
not clear whether continued RF applications with prolonged
procedure time using AF termination as the endpoint will provide
a beneﬁt to patients or not.7. Indication for catheter ablation for long-standing
persistent AF
As shown above, the clinical outcome following the ablation
procedure has demonstrated that not all patients can beneﬁt from
ablation. We now focus on how we can determine who will be a
good candidate for operation prior to the procedure. Several
clinical variables have been shown to be correlated with ablation
procedure outcome in patients with long-standing persistent AF,
including the left atrial dimension on echocardiogram and the
duration of persistent AF. McCready et al. [29] demonstrated
that LA size (larger than 43 mm) was an independent predictor of
AF recurrence following ablation of persistent AF. In contrast,
Matsuo et al. [30] showed that both the surface electrocardio-
graphic AF cycle length (r142 ms) and the duration of contin-
uous AF (421 months) are predictive of AF recurrence after
persistent AF ablation. To avoid harmful procedures in highly
advanced cases, we need additional criteria to determine the
appropriate indications for catheter ablation in patients with
long-standing persistent AF.8. Conclusions
Non-pharmacological rhythm control of atrial ﬁbrillation is of
increasing importance in our aging society. Advancement in
catheter ablation techniques over the last decade has provided
a cure for AF patients, with a nearly established efﬁciency for
paroxysmal cases. Since ablation of chronic AF cases is still
challenging, early treatment of paroxysmal AF beforetransformation to the persistent or chronic form is mandatory.
For ablation of long-standing persistent AF, there is a consensus
that PVI is the ﬁrst-line approach, similar to paroxysmal AF.
However, there are wide variations in the adjunctive approaches
to modify the atrial substrate in persistent AF, and data compar-
ing the effectiveness of these adjunctive approaches are still
lacking. Large scale controlled trials evaluating the effect of
catheter ablation on diverse patient populations over the long-
term are necessary to establish the appropriate approach for long-
standing persistent AF.Conﬂict of interest
There is no conﬂict of interest.
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